PAVmed Inc. 13D and 13G filings for Lucid Diagnostics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-12 4:30 pm Unchanged | 2024-11-22 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 31,302,444 52.700% | 0 (Unchanged) | Filing |
| 2024-02-20 4:45 pm Sale | 2024-02-15 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 31,302,444 65.200% | -3,331,747 (-9.62%) | Filing |
| 2024-02-02 5:11 pm Purchase | 2024-01-26 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 34,634,191 72.200% | 3,331,771 (+10.64%) | Filing |
| 2022-12-02 5:22 pm Purchase | 2022-11-30 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 31,302,420 73.700% | 3,375,230 (+12.09%) | Filing |
| 2021-10-27 5:26 pm Purchase | 2021-10-18 | 13D | Lucid Diagnostics Inc. LUCD | PAVmed Inc. PAVM | 27,927,190 75.500% | 27,927,190 (New Position) | Filing |